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Abstract
Bedi, Shimpi., M. S., Department of Biological Sciences, Wright State University,
2008.
Characterization of Microtubule Depolymerization by the HIV Protein Rev.

The HIV-1 Rev protein enables the nucleocytoplasmic export of unspliced or
partially spliced mRNAs that is required for the synthesis of structural proteins. By
doing so, it regulates the switch to the late phase of the viral replication cycle
(Cullen, 1992). This regulatory control over viral replication makes Rev an
attractive target for anti-viral intervention. The development of anti-viral remedies
is hindered because the three-dimensional structure of Rev has not yet been solved
by X-ray crystallography and NMR. Rev, which polymerizes into regular hollow
filaments at high concentrations, forms side-to-side and end-to-side interactions
making it prone to aggregation and precipitation (Wingfield et al., 1991). Watts et
al. (2000) in an attempt to solve the solubility of Rev discovered a novel interaction
between Rev and tubulin. They observed that Rev filaments react with microtubules
(MTs) to form Rev-tubulin toroidal (RTT) complexes showing that Rev is a
microtubule depolymerizing agent that possibly mimics the mechanism used by
Kinesin-13 proteins, themselves potent microtubule depolymerases.
The first goal of the experiments conducted here was to develop a sedimentation
assay capable of measuring Rev stimulated microtubule depolymerization. Under
the conditions employed here, Rev tubulin toroidal complexes (RTTs) were not
formed due to limiting concentrations of magnesium ions so that the amount of
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tubulin released from microtubule polymers would not reform high molecular
weight complexes that would sediment in our assays.
Initial experiments determined that bacterial expressed Rev was capable of
depolymerizing GMPCPP stabilized microtubules. Depolymerization was not
affected by the oligomeric state of Rev. Rev polymerized into filaments or
maintained as monomers by the addition of high salt concentrations were equally
able to depolymerize microtubules. Microtubule depolymerization appears to be
partially dose dependent and occurs at concentrations as low as 300 nM. At low
concentrations of Rev, more tubulin is released from the microtubule polymer than
there is Rev present in the reaction. This suggests that Rev either has higher affinity
for microtubule ends in the lattice or that Rev multimerization is important for
depolymerization activity. Depolymerization occurs quickly which is consistent
with the findings of Watts et al. (2000). In contrast to the findings of Watts et al.
(2000) who demonstrated a complete disappearance of Taxol stabilized
microtubules when treated with Rev, Rev was unable to completely depolymerize
microtubule polymers stabilized by GMPCPP.
Key words: HIV, Rev, Kinesin-13, microtubules, tubulin
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Introduction
Human immunodeficiency virus-1 (HIV-1) causes human acquired immune
deficiency syndrome (AIDS) (Cullen, 1991). Productive infection requires the
expression of proteins encoded by singly spliced or unspliced viral mRNAs.
Expression of these proteins requires Rev, a 116 amino acid long, 13 KDa viral
transactivator that interacts with one or more cellular factors to promote the export
of these RNAs (Cullen and Malim, 1991). In the absence of Rev, these mRNAs are
retained in the nucleus and are either spliced to completion or are degraded (Pollard
and Malim, 1998). Mutational studies and proviral rescue assays demonstrate that
Rev is essential for virion production and viral replication (Feinberg et al., 1986).
This ability of Rev to regulate the replication of virus makes it a viable target for
anti-viral drugs. Presently, reagents that reduce Rev expression (e.g. RNAi,
ribozymes, and antisense oligodeoxynucleotides) or interfere with Rev function
(e.g. decoys, antibiotics, and transdominant mutations) illustrate the potential for
effectively inhibiting viral infection by inhibiting Rev function (Dayton et al.,
2000).
Rev is a 13 KDa RNA binding phosphoprotein that shuttles between the nucleus
and cytoplasm of expressing cells. It mediates the early to late shift in viral gene
expression (Cullen, 1998). Rev is imported into the nucleus due to the presence of
arginine-rich motif (ARM) that contains a nuclear localization signal (NLS) (Figure
1). The NLS interacts directly with importin-β that targets Rev to nuclear pore
complex (Truant and Cullen, 1999). This interaction is disrupted by Ran-GTP
(Pollard and Malim, 1998) releasing Rev into the nucleus where it is free to bind the
1

Rev response element (RRE). The RRE is an RNA stem-loop structure present
within the 3’ intron present in incompletely spliced or unspliced viral mRNAs
(Pollard, Malim 1998). Nuclear export of Rev-RRE complexes is mediated by a
nuclear export signal (NES), a stretch of leucine-rich residues (residues 73-83)
present towards the C-terminus of the protein. The NES interacts with the export
factor Crm1 (Chromosome Region Maintainenance gene 1)/exportin 1 and RanGTP that together target Rev-RRE complexes to the cytoplasm. After the
dissociation of the Rev/RRE/CRM1 complex in the cytoplasm, Rev re-enters the
nucleus for another round of transport (Hope, 1999).
Multimerization of Rev on the RRE ensures that cellular concentrations must be
sufficiently high and there is not a premature shift to late gene expression.
Multimerization provides an explanation for the high incidence of latent infection
by HIV-1 (Malim and Cullen, 1991). Mutagenesis has identified (residues 18-26
and 54-56) that flank the ARM (residues 34-50) as being important for
multimerization (Malim and Cullen, Brice et al., 1991). Rev cooperatively binds the
RRE through protein-protein and protein-RNA interactions (Heaphy et al., 1991).
In vitro assays show that eight or more Rev monomers may be bound to a single
RRE (Malim and Cullen, 1991). Studies on Rev-RNA co-assemblies show that Rev
monomers first bind the RRE (Malim et al., 1990) and then multimerizes rather
than Rev multimers forming as a requirement to bind the RNA. Consequently, RevRNA complexes form at lower protein concentrations than are known to be required
to form multimeric filaments (Malim and Cullen, 1991). NMR spectroscopy of Rev
peptide bound to stem-loop IIB of the RRE showed that the amino acids that make
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important base-specific contacts with the RRE are Arg35, Arg39, Asn40, and Arg44
(Battiste et al., 1996). Thr34 forms both peptide-peptide and RNA-peptide
interactions and makes contact with the phosphate backbone of the RRE. In
addition to Thr, six arginines at amino acid positions 38, 41, 42, 43, 46, and 48
make either hydrogen-bonding or simple electrostatic interactions with the
phosphate backbone on the RRE (Battiste et al., 1996).

Biochemical characteristics of Rev
Depending on its concentrations, Rev may persist as monomer, an oligomer, or
long hollow filament. In low salt buffers (50 mM NaCl), filament formation occurs
at Rev concentrations greater than 80 µg/ml by a process that is temperature
dependent (Heaphy et al., 1991). Rev filaments consist of dimers arranged in a sixstart helical pattern in which N-terminal helical segments are present in the inner
walls of the tubes (Wingfield et al., 1991, Watts et al., 1998). Filament formation is
not dependent on the multimerization domains present on either side of the ARM
since mutants deficient in multimerization (M4 and M7) are capable of forming
filaments (Watts et al., 1998). Multimerization refers to the oligomerization of Rev
monomers at the high affinity site on the RRE whereas filament formation refers to
Rev polymerization into long, stable tubes (Watts et al., 1998). Rev filaments form
side-to-side and end-to-side interactions making them prone to aggregation and
precipitation (Wingfield et al., 1991).
The three-dimensional structure of Rev has not been solved by X-ray
crystallography and NMR because of its tendency to aggregate and precipitate.
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Nonetheless, there is substantial low-resolution structural information obtained by
biochemical techniques and mutagenesis. Circular dichroism measurements of Rev
mutants in which residues 68-112 or 93-112 were deleted indicated that the Nterminus contains most of the helical properties (Auer et al., 1994). This confirmed
the computer predictions suggesting Rev possesses an N-terminal helix1-loop-helix2
motif (Auer et al., 1994). There is approximately 50% α-helix and 25% β-sheet.
The N-terminal of helix1 and the C-terminal of helix2 (corresponding to residues 924 and residues 34-62 respectively) likely contact each other in a manner exposing
a hydrophobic patch comprised of residues Leu18, Ile19, and Leu22 on helix1 and
I52, I55, and I59 on helix2 that is involved in intermolecular binding (Thomas et al.,
1998). Thus, the two multimerization domains form a single exposed hydrophobic
surface patch that form a surface for interactions with other Rev molecules (Thomas
et al., 1997). This model is confirmed by solid-state NMR analysis on Rev fibrils
that further shows that both monomeric and filamentous Rev have similar helix
contents (Blanco et al., 2001). Not much is known about the C-terminus except that
the circular dichroism indicate that this half is partly helical (Havlin et al., 2007).

Rev-MT Interactions
To facilitate drug design, Steven and collaborators (Wingfield et al., 1991, Watts
et al., 1998, 2000) attempted to determine the solution conditions suitable to study
the structure of Rev. Rev normally tends to aggregate in solution at concentrations
required for crystal growth (Thomas et al., 1997, Wingfield et al., 1991, Heaphy et
al., 1991, Karn et al., 1991). Since the presence of arginine-rich region makes Rev
highly basic (pI= 9.2), they predicted Rev would behave better with an acidic
4

partner or acidic environment. Watts et al., (2000) found that Rev filaments could
be depolymerized effectively by polyanions such as poly G, poly dG, and
polyglutamate. As polyglutamate is found in the C-terminus of the tubulin
monomers that are positioned on the surface of MTs, Watts et al. (2000) suggested
that solubility of Rev might be improved with the addition of tubulin. Tubulin
heterodimers, of course can be polymerized into microtubules (MTs) that play
important roles in cell division, cytoplasmic organization, and maintenance of cell
polarity (Desai et al., 1999). They predicted that there would be an interaction
between the basic ARM of Rev and the acidic polyglutamate tracts on the tubulin
monomers.
Preliminary investigations were made by mixing Rev filaments with taxol
stabilized MTs or colchicine-treated tubulin heterodimers. Watts et al. (2000)
observed that purified Rev depolymerizes MTs and forms bilayered ring like
structures, called Rev-tubulin toroidal complexes (RTTs), comprised of Rev and
tubulin (Watts et al., 2000). Rev monomers line the inside and tubulin monomers
line the outside of these rings. Rev-tubulin rings are similar to those formed when
MTs are exposed to cold temperatures (Melki et al., 1989) or certain anti-mitotic
drugs, and in the presence of Kinesin-13 proteins, a unique sub-family of nonmotile MT depolymerizing proteins (Moores et al., 2003). Reciprocal titrations
showed that the excess protein remained in the filamentous form, indicating that
depolymerization and formation of RTTs were not a buffer effect (Watts et al.,
2000). The RTTs form even in the absence of tubulin’s polyglutamate tail
suggesting that this interaction is more specific than a simple electrostatic
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interaction between the ARM of Rev and the acidic polyglutamate residues of the
tubulin heterodimer (Watts et al., 2000).
The formation of RTTs was surprising since it implies that Rev, a small
nucleolar protein, has the ability to interact with and depolymerize MTs.
Furthermore, ring formation is not inhibited by the MT stabilizing drug taxol, the
MT destabilizing drug colchicine, or microtubule-associated (MAPS) that usually
stabilize and promote the assembly of MTs (Watts et al.,2000).

Mechanism of Rev-tubulin interaction
A possible explanation for the binding site of Rev on the microtubules comes from
the observation that formation of RTTs complexes can be blocked by maytansine
(Watts et al., 2000). Maytansine, and other drugs like the vinca alkaloids and
vinblastine, compete for a different site near the exchangeable nucleotide site on the
β-tubulin (Rai, 1998). Therefore, Rev might bind β-tubulin at or near the vinca site
forming the basis of Rev-MT interactions. Depolymerization activity is encoded
within Rev’s first 59 amino acids where there is a sequence similarity to the motor
domain of non-motile, MT depolymerizing Kinesin-13 proteins (Figure 2).
The kinesin superfamily is a class of motor proteins that use ATP to translocate
along microtubules or to alter MT structure (Vale et al., 1997). These functions are
mediated by a highly conserved 350 amino-acids force generating element called
motor domain. This domain contains both an ATP binding/hydrolysis site and
microtubule binding sites (Woehlke et al., 1997, Ogawa et al., 2004).
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Mutagenesis indicates that these highly conserved, positively charged MT-interacting
residues are located in three loops on the surface of the motor (Woehlke et al., 1997).
MCAK, the best-studied member of the Kinesin-13 family, shares a sequence
similarity within the motor domain with other members of kinesin superfamily
(Wordeman and Mitchison, 1995). Kinesin-13 proteins are characterized by the
unique position of the conserved kinesin motor domain in the middle of the
polypeptide (Desai et al., 1999). Mutagenesis has shown that N-terminus of MCAK is
responsible for kinetochore binding but is not required for MT depolymerization
(Walczak, 2003). Multimerization facilitates efficient depolymerization of MTs even
though the monomeric protein can depolymerize MTs (Wordeman et al., 1995, EmsMcClung et al., 2007). The catalytic motor domain is capable of causing
depolymerization on its own but the presence of neck (residues present N-terminus to
motor) enhances the efficiency of activity (Wordeman et al., 1995, Walczak, 2003).
The C-terminus is responsible for dimerization of MCAK and prevents latticestimulated ATPase activity (Desai et al., 1999).
Most of the residues that are highly conserved between Rev as well as XMCAK
and KIF2C (murine ortholog of MCAK) reside in helix 2 of Rev and helix 4 (α4) of
XMCAK. Studies done with KIF2C (ADP bound form) by Ogawa et al. (2004)
showed that the main microtubule binding helix (α4) is stabilized by Glu521, Ile523,
and Arg524 of α4 and residues 580, 581, and 583 of α6 by electrostatic and
hydrophobic interactions. As seen in the alignment of Rev with the motile KIF1A
and the non-motile MT depolymerizing Kinesin-13 proteins, there are some residues
common between Rev and KIF1A (Figure 2). However, there is more homology with
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non-motile kinesins than with motile kinesin KIF1A. This indicates that Rev might
also behave like non-motile MT depolymerizing kinesin MCAK. Also, residues
similar with MCAK and Rev but not KIF1A might be important for
depolymerization. It is noteworthy that many of the residues shared between Rev and
MCAK are not present in motile kinesins such as KIF1A suggesting that the shared
residues may be important for MT depolymerization.
Two MCAK homologs- KIF2C and pKinI (Plasmodium falciparum) (Ogawa et
al., 2004, Shipley et al., 2004) (Figure 3) specifically bind MTs at the ends (Desai et
al., 1999) or reach the ends by one-dimensional diffusion (Hunter et al., 2003). Once
these proteins reach the MT ends, they cause a conformational change within the
microtubule lattice leading to depolymerization. ATPase activity is not required in the
early stages of depolymerization and is stimulated after the induction of curvature in
the MT. The curvature is seen only when bound to curved tubulin either in GDP
bound form or at the ends where depolymerization has started (Shipley et al., 2004).
This is supported by the observation that KIF2C can be readily docked onto a curved
MT structure but not a straight MT (Ogawa et al., 2004). By comparison, Rev also
inhibits the formation of microtubule asters formed in vitro from mitotic frog egg
extracts suggesting that Rev has the ability to interact with MTs and affect their
polymerization state in a cellular environment (Watts et al., 2000). Therefore, it is
likely that Rev-MT interactions might be similar to Kinesin-13 proteins.
Mutagenesis has identified regions containing highly conserved residues that play
an important role in binding and depolymerization of MTs in Kinesin-13s. The
mutant constructs were prepared by removing the N-terminal domain, the neck and/or
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the C-terminal domain or by removing amino acids in catalytic domain of the protein.
Two of the important regions were- KVD (Lys293-Val294-Asp295) and KEC
(Lys268-Glu269-Cys270) (Shipley et al., 2004). The KVD motif in loop L2 makes a
rigid, finger-like structure extending out from the catalytic core. Each residue in KVD
is critical for causing MT depolymerization since mutating even one of the residues
results in reduction of activity by 30-50% (Ogawa et al., 2004). Deletion of all three
residues results in 11-fold reduction in activity (Ems McClung et al., 2007).
However, these mutations have no effect on MT binding. Mutations in KEC,
however, results in lower MT binding (Ogawa et al., 2004). Mutating one of the
residues within KEC motif (E529A) causes 4.5-fold reduction in depolymerase
activity of MCAK. Another mutation (R522A) within α4 causes 2-fold reduction in
depolymerase activity of MCAK (Ems McClung et al., 2007).
Residues 34-70 in Rev correspond to residues 506-543 in XMCAK that reside in
helix 4 and the region responsible for MT binding (Watts et al., 2000). The helix 2 in
Rev contains most of the Rev-XMCAK shared residues. The corresponding region of
Kinesin-13 that is similar to Rev is L11-α4-L12, a region that provides anchorage
around the switch II cluster on the MT surface and plays an important role in
interaction with MTs (Shipley et al., 2004) (Figure 3). Residues shared between Rev
and XMCAK are exposed to the surface and therefore are free to interact with
microtubules. RevE57A has a high probability of being surface exposed as
crystallographic data suggests that the corresponding residue in XMCAK (E529) is
surface exposed (Ogawa et al., 2004). This residue is conserved in Kinesin-13
proteins and upon mutation causes 4.5 fold reduction in depolymerization activity
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(Ems-McClung et al., 2007). RevE47 is common to most Kinesin-13 proteins and
may play a role similar to RevE57 (Ogawa et al., 2004). Rev R50 corresponding to
XMCAK R522 might have a role in MT binding rather than depolymerization since
mutation of this residue in XMCAK caused two-fold reduction in the activity (EmsMcClung et al., 2007). Both E57 and E47 might be capable of destabilizing
microtubules since the microtubules are destabilized by their own E-hooks (Cterminal polyglutamate tracts of tubulin monomers exposed on the surface).
If Rev binds and depolymerizes MTs in a mechanism comparable to that of
Kinesin-13 proteins, shared residues should play similar role of either MT binding
or depolymerization in both proteins. Both cause curved structures when mixed
with stabilized MTs and depolymerization occurs from both ends of the MT. A
limited region of Rev shows statistically significant 36 amino acid similarity with
the catalytic domain of XMCAK and KIF2C. Some of these residues are not
conserved in motile kinesin KIF1A indicating that these residues may play an
important role in MT depolymerization since motile kinesins lack depolymerase
activity.
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Specific Aims
The long-term goal of this research is to identify residues of Rev that are
responsible for binding and depolymerization of MTs. By comparing the
depolymerization activity of wild-type Rev with Rev that has been mutated in the
area of sequence similarity with Kinesin-13 proteins, it should be possible to
identify residues that are directly involved in MT binding and depolymerization. To
do this, the assays for measuring interactions with MTs need to be developed and
optimized. I propose to optimize microtubule depolymerization assays using wildtype Rev that will allow us to test the hypothesis that Rev depolymerizes MTs by a
mechanism comparable to Kinesin-13 proteins. Specifically, I propose to duplicate
the experiment done by Watts et al., 2000 whose experiment demonstrated the
formation of Rev-tubulin rings when taxol-stabilized GTP treated MTs were mixed
with Rev. Dissection of the Rev-induced depolymerization of MTs required (a)
purification of tubulin (b) purification of Rev (c) adapting sedimentation assay to
measure the time-dependence and dose-dependence of Rev-MT interaction.
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Materials and Methods
SDS-PAGE and immunoblotting
Protein samples were prepared by mixing 10 µl of protein with 5 µl of 2 X SDSPAGE protein sample buffer, boiled for 3 min, and the entire volume was loaded
and proteins separated by size on polyacrylamide gel (%T=15%) using SDS-PAGE
at constant current of 30 mA/gel for 60 min. The gels were recovered and stained
overnight and destained with gel destaining solution until the protein bands were
visible without background. Images of the gels were captured using Adobe
Photoshop and analyzed using NIH-image to determine protein concentration.
For immunoblotting, protein samples were boiled in SDS-PAGE 2 X protein
sample buffer, resolved by SDS-PAGE and transferred to a nitrocellulose
membrane equilibrated in 1X transfer buffer at 50W, 100 mA, and 50V for two
hours. The membrane was stained using ponceau stain and destained using 5%
acetic acid solution until the protein bands were seen on the membrane. The blots
were washed with TBST until the pH was 7.4 and incubated in 5% milk TBST
blocking solution overnight. The blocking solution was replaced with 1X TBST,
washed three times every 10 minutes (22˚C) on a rocking table. The blot was
allowed to incubate for 1 h in 10 ml of primary antibody [10 Ab, Tubulin-specific
DM1α-1:5000 and Rev specific rabbit antiserum- 1:2000] solution prepared in 1X
TBST. After 1 h, the primary antibody solution was recovered and replaced with 1X
TBST and washed three times every 10 min. After the washes, the blot was allowed
to incubate in 10 ml of secondary antibody solution [1:100,000 HRP-conjugated
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goat antimouse, 1:100,000 goat antisheep] prepared in 1X TBST (pH 7.3) for 1 h.
After the blot was washed three times using 1X TBST pH 7.3, it was removed to a
dish containing 10 ml of Pierce SuperSignal West Pico Chemiluminescent substrate
for detection of HRP for five minutes. Image of the blot was captured using
chemiluminescence and protein bands quantified using Fuji Image Gauge software
(V2.02).

Rev expression and purification
a. Plasmid isolation and test expression of Rev
The plasmid pET11d-Rev was kindly supplied by Francisco Blanco (Blanco et
al., 2001). Plasmid DNA was transformed into chemically competent DH5 cells
(Invitrogen, Carlsbad, CA) according to manufacturer’s protocol. Cells were grown
overnight at 37˚C with 225 rpm shaking in Luria-Bertani (LB) broth supplemented
with 100 µg/ml ampicillin (LB/amp). Stocks of overnight cultures of transformed
cells were stored in 15% glycerol at -80˚C. Plasmid DNA was purified from 10 ml
LB/amp cultures using plasmid isolation kits Qiagen (Valencia, CA).
pET11d-Rev DNA was transformed into chemically competent BL-21(DE-3)
cells (Invitrogen, Carlsbad, CA) as described above. 10 ml LB/amp cultures with
single ampicillin-resistant colonies were grown at 37˚C with 225 rpm shaking.
Expression was induced for two hours with the addition of IPTG (isopropyl-β-Dthiogalactopyranoside) to a final concentration of 1 mM. Cells were harvested by
centrifugation at full speed in a benchtop clinical centrifuge at 4˚C. The recovered
pellet was resuspended in 1 ml of Buffer A (400 mM NaCl, 50 mM Tris-HCl pH
13

8.0, 1mM EDTA, 1 mM DTT, 0.5 mM phenyl-methylsulfonylfluoride (PMSF),
sonicated (3 x 30 seconds), subjected to centrifugation at 4˚C. Both soluble and
insoluble fractions were diluted with an equal volume of 2X gel sample buffer (50
mM Tris-HCl pH 6.8, 2% SDS, 10% glycerol, 1% β-mercaptoethanol, 12.5 mM
EDTA, 0.02% bromophenol blue), boiled for 3 min and resolved by 15% protein
gels. Gels were stained with 0.1% coomassie brilliant blue (CBB) in buffer and
destained with 35% methanol, 10% glacial acetic acid or immunoblotted. Protein
fractions from induced and non-induced cultures for both DH5α and BL-21(DE-3)
cells were seen on a coomasie stained gel and western blot to check the expression
level (Figure 3). Once high level of expression of Rev was seen in the induced BL21(DE-3) cells, a larger bacterial culture (1-3L) LB broth (100 µg/ml ampicillin)
was set up at 37˚C.

b.Large scale expression of Rev
A large scale (1-3 L) LB broth-ampicillin bacterial culture was inoculated from a
50-150 ml overnight culture and grown with constant shaking (225 rpm) at 37˚C.
The growth of the culture was checked every 30 min in the spectrophotometer by
measuring absorbance at 600 nm length until it measured 0.6. Cells were then
induced for two hours by the addition of 1 ml of 1M stock of IPTG (1 mM final
concentration) and harvested by centrifugation by spinning at 4,225 x g (Sorvall
rotor GS-3) at 4oC. Recovered cell pellets were frozen in -20˚C until cell lysis.
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c.Purification of Rev
Lysis: Cell pellets were weighed, thawed on ice, mixed with 11 ml of chilled
buffer A (400 mM NaCl, 50 mM Tris-HCl pH 8.0, 1 mM EDTA, 1 mM DTT, 0.5
mM PMSF), mixed thoroughly by vortexing, and sonicated 3 x 30 sec. The mixture
was frozen in dry ice, thawed, and sonicated as described above. Lysate was
subjected to centrifugation at 11,952 x g in a Sorvall centrifuge at 4˚C and the
supernatant was recovered that was either frozen at -80˚C or applied to a Qsepharose column.

FPLC: Rev was purified using an AKTA FPLC with Frac-950 as fraction
collector (Amersham Biosciences). Clarified cell extracts were loaded into a 50 ml
superloop and applied to a HiPrep 16/10 Q FF column equilibrated in 100 ml of
buffer A. After washing the column with five column volumes of buffer A (100ml)
and when the O.D280 of the eluant reached below 0.05, Rev was eluted with three
column volumes of buffer B (800 mM NaCl, 50 mM Tris- HCl pH 8.0, 1 mM
EDTA, 1 mM DTT). Column fractions were resolved by SDS-PAGE (%T=15%) to
confirm the presence of Rev. Peak fractions containing Rev (25-30 ml total volume)
were pooled together and applied to a HiPrep 16/10 Heparin FF column
equilibrated in 80 ml of buffer B. The column was washed with five column
volumes of buffer B or C (1 M NaCl, 50 mM Tris- HCl pH 8.0, 1 mM EDTA, 1
mM DTT) until the O.D280 of the eluant reached below 0.05. A step gradient was
applied and Rev was eluted with 3 column volumes of buffer D (2 M NaCl, 50 mM
Tris-HCl pH 8.0, 1 mM EDTA, 1 mM DTT). Fractions containing Rev were
15

pooled. In some instances, Rev was concentrated by ultrafiltration using Centricon30.
In case of mutants, Rev was subjected to ammonium sulfate precipitation by
adding concentrated stock of the salt to Rev from the heparin column to concentrate
the protein. After centrifugation at 4˚C at full speed in a microfuge and
resuspending the pellets in Karn D buffer (100 µl), the concentration of Rev was
determined spectrophotometrically by measuring the absorbance at 280 nm
wavelength and also densitomterically using ImageJ by comparing the intensity of
Rev bands to BSA standards.

Rev refolding: Fractions containing Rev from the heparin column were
pooled, denatured in 6M urea, and subjected to dialysis against dialysis buffer 1 (50
mM sodium phosphate, 150 mM sodium chloride, 600 mM ammonium sulfate, 50
mM sodium citrate, 1mM EDTA pH 7.0), dialysis buffer 2 (50 mM sodium
phosphate, 150 mM sodium chloride, 50 mM sodium citrate, 1mM EDTA pH 7.0),
and dialysis buffer 3 (20 mM Hepes, 100 mM sodium chloride, 50 mM sodium
citrate, 1 mM EDTA pH 7.0) by changing the buffer solutions twice a day at 4˚C as
described by Watts et al., 1998, 2000. Dialysis buffer 3 served as the storage buffer.
The Rev filaments were concentrated using either centricon-30 (1,500 x g for 10
min) or by pelleting filaments at 90,000 rpm for four hours in TLA100.3 rotor at
4oC (Watts et al., 1998). Rev filaments were stored at 4˚C at all times.
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Concentration determination: The concentration of Rev solutions was
detected both spectrophotomterically by measuring absorbance at 280 nm
(

280=8.34 mM)

and densitometrically as mentioned above.

Purification of tubulin
Tubulin was purified by repeated cycles of polymerization at 37˚C and
depolymerization at 4˚C cycles in the presence of ATP, GTP, MgCl2, and glycerol
and subsequently chromatographed over the phosphocellulose column (Desai and
Walczak, 2001). Four fresh bovine brains were transported to the lab in a large
cooler containing 3 L precooled 1.5% NaCl. Meninges and clots were stripped from
the brains at 4˚C and the brains were weighed and homogenized with 1-1.1 volumes
of PB (Pipes buffer: 0.1 M Pipes, pH 6.8, 0.5 mM MgCl2, 2 mM EGTA, 0.1% 2mercaptoethanol, 1 mM ATP ) twice for 15 s in a blender until homogeneous. The
suspension was poured into SS-34 centrifuge tubes and spun for 45 min, K factor
714 at 4˚C. The supernatant was recovered and supplemented with pre-warmed
glycerol (50% volume), ATP (final concentration 1.5 mM), GTP (final
concentration 0.1 mM), and MgCl2 (final concentration 3.5 mM). This mixture was
mixed vigorously and incubated at 37˚C water bath for 30 min. The mixture was
spun in a centrifuge at 35˚C in a GSA rotor at 25,805 x g for 306 min, K factor
1057.9 and the gelatinous pellets were transferred to a beaker on ice and
resuspended in 10 ml cold PB with ATP and BME. Pellets were solubilized by
douncing until homogeneous and transferred to a second chiller beaker. Douncing
was repeated a second time and after incubation on ice for 40 min, the mixture was
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spun for thirty min at 4˚C in 50.2 Ti rotor at 40,000 rpm for 30 min . The
supernatant was decanted into a graduated cylinder, supplemented with pre-warmed
50% glycerol, GTP (0.5 mM final concentration), and MgCl2 (4 mM final
concentration), and allowed to polymerize at 37˚C for 40 min. The mixture was
spun in a 50.2 Ti rotor at 40,000 at 35˚C for 30 min and the recovered pellets were
kept warm until the supernatant was decanted from them. The pellets were scooped
in a beaker set on ice and resuspended in CB (50 mM Pipes, pH 6.8, 1 mM EGTA,
0.2 mM MgCl2), dounced until smooth and the protein concentration checked by
Bradford using BGG as standard. After incubation on ice for 40 min, tubulin was
centrifuged at 4˚C in a 50.2 Ti rotor at 40,000 for 30 min. Supernatant containing
the tubulin heterodimer was recovered and chromatographed on phosphocellulose
column (approx. 30 cm high x 3.2 cm ID-volume 200 ml) at a flow rate of 2
ml/min. Tubulin (phosphocellulose column or PC) eluted after 100 mls had passed
through the column and the concentration of the fractions was checked again.
Fractions that had greater than 1mg/ml tubulin were combined. The column was
washed with 5 volumes of 1M KCl in CB to elute MAPS. The tubulin and MAPS
were aliquoted in smaller fractions, frozen in liquid nitrogen, and stored at -80˚C.
The PC column was equilibrated with 10 volumes of CB (0.1% NaN3) for storage.

Rev-Microtubule Sedimentation assay
Single aliquot (200 µl) of PC tubulin was quickly thawed, diluted with MEM
buffer (100 mM MES, 1 mM MgCl2, 1 mM EGTA pH 6.4), and incubated on ice
for 10 min, and spun at 4˚C using an ultracentrifuge in a chilled TLA100.3 rotor
(350,000 x g for five min). The supernatant containing tubulin heterodimer was
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transferred to an eppendorf tube, mixed with GMPCPP, and placed in a 37˚C water
bath for 30 minutes. The rotor (TLA100.3) was warmed to 37˚C for the next spin.
After an incubation time of 30 min, tubulin was transferred to an ultracentrifuge
tube, and microtubules (MTs) were pelleted at 35˚C (350,000 X g for five minutes).
The pellet was dissolved and brought up in 30-40 µl of MEM buffer (22˚C) by
pipetting up and down and stored at room temperature until further use. A small
volume (3 µl) of MTs was removed and mixed with 57 µl of chilled MES/CaCl2,
incubated on ice for 15 min, and the concentration of tubulin was determined
spectrophotometrically using the coefficient (

280

= 115,000 M-1cm-1). The stock

microtubules were diluted to a final concentration of 3 µM in MEM buffer to set up
reaction mixes with either different concentrations of wild-type Rev or buffer alone.
Wild-type Rev protein solution (stock concentration 45 µM) or buffer alone
(MEM buffer) were added to polymerized microtubules to the final concentrations
as indicated in the figures (0.3 pM to 3 µM). Rev was diluted just before addition to
the MTs. Reaction was started by the addition of Rev (molar ratio of 1:1) to the
diluted MTs. A volume of 20 µl of the reaction mixes was aliquoted in centrifuge
tubes and allowed to incubate at 22˚C until spun in the ultracentrifuge. After an
incubation time of 10-60 minutes, the tubes were placed in TLA100 rotor warmed
at 22˚C, and centrifuged at 350,000 x g for five minutes. The supernatant (20µl)
was carefully recovered to labeled eppendorf tubes containing 20 µl of 2X sample
buffer, boiled for 3 min, and stored at -20˚C. The pellets were mixed with 40 µl of
1X sample buffer by pipetting up and down several times, transferred to an
eppendorf tube, boiled for 3 min, and also stored at -20˚C.
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The proteins in the supernatant and pellet fractions were resolved by SDS-PAGE
(%T=15%). Gels were either stained with CBB or transferred electrically to a
nitrocellulose membrane equilibrated in 1X transfer buffer as described above. The
amount of percentage of tubulin in the supernatant of no Rev control was subtracted
from the supernatant of MT-Rev mixtures. The percentage of tubulin released in the
supernatant was plotted as a function of time and against different concentrations of
Rev. Finally, the number of moles of Rev added was plotted against the number of
moles of tubulin released in the supernatant for the concentration dependent
experiments.

Statistical Analysis
All analyses were conducted using SAS version 9.2 by Mrs. Beverly K. Grunden,
Statistical Consultant, at Wright State University. For time dependence, it was
determined if the regression line for the date is significantly different from zero. A
linear regression was run with percentage of tubulin as the dependent variable and
time as the independent variable. For the dilution and time dependence, model
assumptions could not be met by the raw data or by transformation. This was due to
having too few observations at the higher levels of dilution, yielding a variance of
zero at two of these levels. Therefore, a one-way ANOVA was used that ignored
time, effectively pooling all the data at a given dilution level into one group. For the
centrifugal speed analysis, a two-way ANOVA with percent of tubulin as the
dependent variable and factor speed (5 levels) and group (2 levels: control or
Rev+MT) was used. The model was tested by removing the interaction term as it
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was not significant. Posthoc tests were run using Tukey’s HSD to test the overall
level of significance.
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Results
This study attempted to measure MT depolymerization stimulated by the
addition of Rev using sedimentation assay commonly used to quantify the
depolymerase activities of Kinesin-13 proteins (Desai et al., 1999). The buffers
used in this study were derived from Watts et al. (2000) who first demonstrated the
formation of Rev-tubulin rings in MES buffers (see Materials and Methods).
Briefly, Rev was mixed with GMPCPP-stabilized MTs and, after a period of
incubation (10-60 min), Rev-MT mixture was centrifuged to separate tubulin
released from the MT polymer. Proteins present in the supernatants and pellets were
then subjected to SDS-PAGE and the amount of tubulin was quantified by
densitometry as described in the Materials and Methods. Because this assay
required microgram amounts of highly purified Rev and tubulin, my first specific
aim was to purify proteins required for these assays: wild-type Rev protein and
tubulin heterodimers.

Purification of wild-type Rev
Previous studies have shown that biologically active protein can be expressed in
Escherichia coli cells (Wingfield et al., 1991, Watts et al., 1998, 2000, Brice et al.,
1999). The expression plasmid encoding wild-type Rev used in this study (pET11dRev), a generous gift from Blanco et al. (2001), was transformed into competent
BL-21(DE-3) cells (Invitrogen, Carlsbad, CA) and expression of Rev protein was
confirmed using SDS-PAGE (Figure 4). To optimize Rev expression to maximize
yields of full-length Rev while minimizing the yield of truncated protein, test
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experiments were conducted with 10 ml cultures that showed that incubation longer
than 3 hours resulted in an accumulation of Rev that appears proteolytically clipped
(data not shown). With the conditions optimized, Rev was purified from 1-2 L
cultures by FPLC methods described by Karn et al. (1995). Representative results
are shown in Figure 5. Cell lysates clarified by centrifugation were
chromatographed using a Q-Sepharose column that isolated Rev-RNA complexes.
Column fractions were resolved by SDS-PAGE and typical results are shown in
Figure 5 C. The vast majority of whole cell extract (WCE), a highly concentrated
mixture of proteins of different molecular weights, did not bind the Q-sepharose
column as indicated by the amount of protein in the flow-through (FT) fractions and
the substantial peak on the chromatogram. After washing the column with three
column volumes of buffer containing 400 mM NaCl (CW), there is a elution of
proteins with 800 mM NaCl (EL) (Figure 5A, C) that contained Rev along with
relatively small amount of contaminating proteins. The presence of Rev was
confirmed by western blotting (not shown).
Rev containing fractions were pooled and applied to a heparin-sepharose
column. Representative results are shown in Figure 5 B. The flow-through fractions
(FT) that did not bind the column do not contain Rev showing that most of the Rev
bound the column. Rev eluted from the heparin column in high salt buffer (2M
NaCl) corresponding to the single peak on chromatogram and is seen as a single
purified band on a coomassie stained gel at 19 kilodaltons (KDa) (Figure 5D). The
anomalous gel mobility is consistent with published results (Malim and Cullen,
1989). The eluted protein is antigenically identical to Rev and can be stained using
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Rev-specific antibodies.
Purified Rev was denatured with 6M urea and refolded according to the methods
described by Watts et al. (1998). Under these conditions, Rev assembles into
filaments that do not have a propensity to aggregate. Purified Rev appears as a
single band when resolved by SDS-PAGE as seen in Figure 5E. The concentration
of purified Rev was determined spectrophotometrically as mentioned in Materials
and Methods. A representative image of the PAGE-based quantitation is shown in
Figure 5E and the graph generated to calculate the concentration of Rev is shown in
Figure 5F.
As a rule, 3.4-4.0 g of E. coli cells were harvested by centrifugation per liter of
culture (Table 1). An average of 6 ml of 0.6 mg/ml Rev was recovered from the
heparin-sepharose column and subjected to refolding. The summary of purification
attempts is summarized in table 1 below. By comparison, the protein yield has been
reported to be about 3.5 mg per gram wet weight of E. coli cells (Wingfield et al.,
1991) and 100 mg/ml (Watts et al., 2000).
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Table: 1
Yields of purified wild-type Rev from BL-21(DE-3) E.coli cells
Attempt

Volume of cell culture

Yield (mg)

1.

1L

1.5

2.

1L

1.1

3.

1L

1.4

4.

2L

2.3

5.

1L

0.6

6.

1L

1.4

7.

1L

0.3

8.

1L

0.9

9.

2L

3.1

Rev purified this way has been analyzed using mass spectroscopy that revealed
that the protein is pure indicated by a single peak corresponding to 13 kDa and is
free of contaminants (A. Sharma, personal communication). The protein yield has
been in the range of 1-1.2 mg/ml and these results were reproducible from
purifications of different lots.

Purification of Rev mutants
Attempts to purify mutants of Rev protein defective in multimerization (M4 and
M7) or RNA binding (M5 and M6) using similar methods are discussed in detail in
Appendix (Figure A1, A2). Purification was hindered by the inability of Rev to bind
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the heparin-sepharose column resulting in low concentration of Rev and was
associated with contaminating proteins that made it unsuitable for use in
biochemical assay. These mutants were excluded from use in sedimentation assay
due to the presence of contaminants.

Purification of tubulin
Tubulin used in this study was purified from bovine brains as described in
Materials and Methods. Result of the purification is shown in Figure 6. The
chromatogram and SDS-PAGE of purified tubulin is shown in Figure 6A. Tubulin
is present in the flow-through fractions and appears a single band on a coomassie
stained polyacrylamide gel migrating at 50 kDa (Figure 6C). The final
concentration of pure tubulin was 22 µM and was aliquoted into 50-200 µl
fractions, frozen on liquid nitrogen, and stored at -80oC. Microtubule associated
proteins (MAPS) were eluted from the column in 1M KCl corresponding to the
peak in the chromatogram (Figure 6B).

Rev storage and aggregation
Rev eluting from the heparin-sepharose column was dialyzed to form filaments
as described by Watts et al. (1998, 2000). Under the conditions employed, Rev
filaments were stable for 4-5 months. As seen in Figure 10, Rev does not show
precipitation and falling out of solution when present in elution buffer (2M NaCl) or
storage buffer (Citrate buffer). Rev retains activity for 4-5 months at 4oC but there
is a loss of depolymerization activity afterwards. Samples stored for a period longer
than 5 months show small Rev derived peptides (Figure 11) that correlates with the
decrease in activity.
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RTTs and the role of magnesium
Watts et al. (2000) observed that citrate ions, required to prevent aggregation of
Rev in the storage buffer, chelates magnesium ions essential for the formation of
RTTs. However, RTT formation is rescued if magnesium is supplemented in excess
to the concentration of citrate ions (1-2 mM). When Mg2+ is limiting, a soluble Revtubulin complex forms. In the presence of 1-2 mM Mg2+ excess, RTT complexes
form (Watts et al., 2000). Under my experimental conditions, there was an excess
of citrate relative to magnesium (3.0-12.5 mM and 0.7-0.9 mM respectively).
Therefore, RTTs are not likely to be formed under our conditions and instead a
soluble Rev-tubulin complex is predicted. The omission of magnesium and
therefore the failure to form RTTs should simplify interpretation of results from our
sedimentation assays. Since RTTs will not form, all tubulin released should not be
pelleted by high speed centrifugation and will not be confused with pelletable MTs.

Measurement of Rev: Microtubule Interactions
With purified proteins in hand, the next aim was to adapt sedimentation assays
used to measure MT depolymerase activity of MCAK in order to quantify the
ability of Rev to depolymerize MTs. These assays involve mixing MTs with a
depolymerizing agent and after a period of incubation, separate high molecular
weight MTs from low molecular weight tubulin released from the polymer by
centrifugation (Desai et al., 1999). The ultimate goal of this assay is to be able to
measure difference in the amount of depolymerization by Rev protein harboring
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mutations.
The assays used must have the ideal solution conditions that allows Rev function
and allows the measurement of the time and concentration dependent properties of
Rev-MT interactions. To quantify Rev:MT interactions in anticipation that mutants
will exhibit different activities, It was necessary to develop the buffer conditions for
the sedimentation assay and then test the hypothesis that Rev depolymerizes MTs in
a time-dependent and dose-dependent manner. Study of Rev induced MT
depolymerization required the ability to form functional MTs from tubulin
heterodimers that are stable for the time period used in this assay. Wild-type Rev
and MTs had to be stable in control buffers to make statistically significant
conclusions. Figure 7A shows that when Rev and MTs are separately added to
reaction buffers, the percentage of pelletable proteins is constant for one hour. This
indicates that Rev filaments dissociate into different sized complexes and does not
aggregate during the reaction. Similarly, it shows that GMPCPP stabilized MTs do
not depolymerize during the reaction unless a depolymerizing agent is added.
Lastly, neither Rev nor tubulin is degraded during the reaction as the total amount
of both proteins remains constant in each sample (supernatant and pellet). The
mixing of Rev and MTs, however, results in the release of tubulin from the polymer
as the fraction of Rev present in the supernatant increases with time (Figure 7C).
This confirms the results of Watts et al. (2000) that Rev depolymerizes stabilized
MTs.
Preliminary experiments were done using a microtubule compatible buffer
BRB80/DTT. This buffer was used since sedimentation assays done to characterize
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the depolymerase activity of Kinesin-13 used BRB80 as reaction buffer. However,
there was poor polymerization of stable MTs in this buffer. This necessitated use of
the buffers (MES and MEM) used by Watts et al. (2000) (see Materials and
Methods). The percentage of tubulin present in supernatant when stabilized MTs
were placed in MEM buffer alone was 12-15% indicating that MTs were not
destabilized in this buffer. This buffer was subsequently used in the time-dependent
and dose-dependent experiments.
Another consideration in the sedimentation assay was to study whether the rate
of tubulin release varies with initial state of Rev when it is added to the MT. Rev
exists in monomers in high salt buffer. The protein assumes filamentous structure
when refolded using the methods described by Watts et al. (1998). Therefore, it was
imperative to determine if the Rev storage buffer affected MT depolymerization. At
low concentrations or in the presence of high salt (>750 mM NaCl), Rev exists
predominantly as a monomer. At high protein concentrations or in low salt
solutions, Rev forms long hollow filaments that tend to aggregate unless carefully
refolded (Wingfield et al., 1991, Tycko et al.). After Rev is denatured and refolded
following the methods of Watts et al. (1998), Rev assembles into filaments that do
not aggregate. Results show that Rev depolymerizes microtubules regardless of the
starting form or the storage buffer the protein is derived from (data not shown).
These results also confirm that depolymerization is not due to buffer effect as the
buffers that the two forms of Rev are stored in have different salt concentrations.
Regardless of the form of Rev added to the reaction, Rev filaments do not
completely pellet upon centrifugation and there is a high percentage (45%) of
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soluble Rev that stays in the supernatant (Figure 7A). It is possible that there is
equilibrium between Rev filaments and oligomers that causes only about half of the
protein to pellet. Alternatively, there might be a formation of filaments of nonuniform lengths and centrifugation probably pellets only the larger ones. To further
characterize Rev-MT interactions, attempts were made to see whether the products
of Rev-MT interactions remain in the supernatant or co-sediment with MT
polymers.
To determine whether Rev-MT interactions were time dependent, GMPCPP
stabilized MTs were mixed with equimolar wild-type Rev, allowed to incubate for
10-60 min, and Rev-MT mixture was centrifuged to separate the supernatant from
pellet. In these experiments, the concentration of MTs was kept the same (3 µM)
while titrating against different concentrations of Rev. At this concentration, tubulin
shows as a prominent band on a coomassie brilliant blue stained gel. Rev is barely
detected with coomassie brilliant blue stained gel but is readily seen with
immunoblotting (Figure 7C).
Investigation of time dependence of Rev-MT interaction will demonstrate if the
reaction is more complex than the reactants simply interacting together to form
products, e.g. rings, spirals etc. Analysis of the data from time dependent
experiments (Figure 7A, B) indicates that there is a range of 12-18 % soluble
tubulin that stays in the supernatant when MTs are placed in buffer alone. With the
addition of equimolar Rev to microtubules, there is a net increase of soluble tubulin
heterodimer in the supernatant over 60 min (30-35%) (p<0.0001), but the increase
in soluble heterodimer is seen as early as 10 min after the addition of Rev (Figure
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7C, D). This result is consistent with the observations of Watts et al. (2000) who
observed transient turbidity immediately after mixing of taxol stabilized MTs with
wild-type Rev. Depolymerization can be attributed to the activity of Rev alone
since GMPCPP stabilized MTs are stable in buffer for the indicated time period (60
min) (Figure 7A).
To demonstrate that Rev-MT interaction is dose-dependent, increasing
concentrations of wild-type Rev were mixed with GMPCPP stabilized MTs,
incubated for 10-40 min, and soluble heterodimer and MT polymer were separated
by centrifugation. Analysis of the stoichiometry required for Rev to depolymerize
microtubules should indicate whether the interaction is enzymatic (like MCAK) or
not and further help speculate on the mechanism of Rev induced depolymerization
of MTs. Results indicate that this interaction is dose dependent. As seen in Figure
8A, addition of increasing concentrations of Rev the reaction mixture causes
increase in the percentage of liberated tubulin in the supernatant. The lowest
concentration of Rev that results in a statistically significant amount of tubulin
released is 300 nM when mixed with 3 µM MTs (molar ratio 1:10) (p<0.05) (see
Materials and Methods for statistical test used). The reason for the 30 nM
concentration of Rev not causing a stastically significant depolymerization of MTs
compared to 0 nM Rev is that the sample size had an N of 1. This suggests that Rev
can depolymerize MTs at concentrations as low as 30 nM. Higher concentrations of
Rev result in saturation seen at a tubulin: Rev molar ratio of 1:4 (Figure 8).
Depolymerization saturates at 37% net tubulin released and the rate of tubulin
release slows down gradually at all concentrations of Rev after 10 min. More
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tubulin is released than the number of moles of Rev added to the reaction at lower
concentrations of Rev (Figure 8A). The average rate of tubulin release is 0.67
pmoles/minute.
It is formally possible that the depolymerization described above might be
dependent upon the starting oligomerization state of Rev and this may explain the
failure of Rev to depolymerize 100% of the MT polymer. It is also possible that
Rev never appears to completely depolymerize the MT polymer because the RTTs
are formed and pelleted. Attempts were therefore made to keep the products of
depolymerization e.g. rings in the supernatant by reducing the centrifugal force at
which the mixture was spun. If rings were formed under our experimental
conditions, then at a reduced centrifugal force, the MT polymer is expected to pellet
due to higher mass but rings, 3.4-4.2 MDa in mass, are expected to stay in
supernatant. To test this, Rev was added to MTs, incubated at room temperature for
20 minutes, and the reaction mixture was subjected to centrifugal forces ranging
from 20,000 x g to 350,000 x g (Figure 9). The percentage of tubulin in the
supernatant at each centrifugal force was calculated and plotted against the
centrifugal forces. Figure 9 indicates that both the controls and the Rev-MT mixture
show increase in the pelletable proteins as centrifugal forces are increased. For the
analysis of the data, a two-way ANOVA with percent of tubulin as the dependent
variable and factor speeds (5 levels) and group (2 levels: control or Rev+MT) was
used. The model was strongly significant, but the interaction term was not
significant. The final model with main effects only was strongly significant
(p=0.0001) (See Methods and Materials for the test used). None of the centrifugal
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forces showed a sharp drop in the percentage of tubulin that would have indicated
the pelleting of Rev-tubulin rings. This is consistent with our data that indicates that
RTTs are not formed.
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Discussion
The long term goal of these experiments was to quantify the results of Watts et
al. (2000) and to test the hypothesis that Rev depolymerizes MTs by a mechanism
similar to Kinesin-13s postulated by Watts et al. (2000). This necessitated the
purification of large amounts of wild-type Rev and comparison of depolymerization
ability of wild-type Rev with mutant forms of Rev. Specifically, by comparing the
activity of wild-type Rev with the mutant form that has point mutations in regions
important for either multimerization or RNA binding, it will be possible to identify
residues important for its function.
The substrate used in the sedimentation assays was GMPCPP-stabilized MTs
unlike the GTP and taxol treated MTs used in the experiments by Watts et al.
(2000). Because the hydrolysis is negligible over the course of polymerization, any
depolymerization of MTs observed can be attributed to the presence of Rev. The
buffer used in the sedimentation assays was a MT compatible buffer MEM (100
mM MES, 1 mM MgCl2, and 1 mM EGTA). When GMPCPP stabilized MTs were
placed in buffer alone, there was a range of 12-18% soluble tubulin heterodimer
present in the supernatant that stayed within this range over 60 min (Figure 7D).
Upon addition of purified Rev to stabilized MTs, the net increase of soluble tubulin
in the supernatant was about 30% over the same period of time indicating that the
assay can measure Rev-induced depolymerization of MTs. This was clearly not a
buffer effect since MTs were stable in buffer alone and showed increase in soluble
tubulin in supernatant only after the addition of Rev (Figure 7).
There is evidence that there is statistically significant time dependence and some
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dose-dependence in Rev induced MT depolymerization (Figure 8). Rev filaments
retained activity for 4-5 months when stored in Rev storage buffer; followed by
decrease in depolymerization activity that correlated with the appearance of smaller
Rev derived peptides seen in western blotting and coomassie stained gel (Figure
11). This was further confirmed by mass spectrometry that showed the presence of
smaller peptides in Rev samples stored for long periods of time (Deacon Sweeney,
personal communication). These smaller peptides seemed to inhibit the activity of
wild type Rev (data not shown).
The MT substrate and depolymerization products had different sizes based on
the results of the sedimentation assay done with different centrifugal forces. In the
event, the sizes were the same, the MT substrate and the products would not have
exhibited differential pelleting. Attempts were made to keep the product of Rev-MT
mixture e.g. rings in the supernatant by spinning Rev-MT mixture at a lower
centrifugal force (20,000 x g to 350,000 x g) (Figure 9). The expectation was that
reduced centrifugal force would separate RTTs from intact MT polymer. None of
the centrifugal forces showed a sharp drop in the percentage of tubulin that would
have indicated the pelleting of Rev-tubulin rings. The explanation is that the
product of depolymerization under these buffer conditions are not ring
intermediates. Also, the citrate concentrations are present in molar excess that
chelates magnesium ions and prevents the formation of rings. It is likely that spirals
are formed as reported by preliminary experiments done by mixing GMPCPP
stabilized MTs with Rev (Watts et al.,2000) . It would be useful to test the effects of
increasing concentrations of magnesium on the products of depolymerization and
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correlate these results with experiments done with taxol stabilized GTP treated
MTs.
There are several means by which Rev can bind MTs and then depolymerize
them. In one set of models, Rev exhibits a preference for MT ends. Once bound, it
depolymerizes them. Alternatively, Rev may bind the MT ends and lattice equally.
That means that Rev must target MT ends before it depolymerizes them. If this is
true, then one would expect either a very low concentration of Rev to target the
ends or Rev has the ability to track to the ends. MCAK, for example, exhibits a
higher affinity for MT ends and also binds the lattice. MCAK bound to the lattice is
known to diffuse along the lattice. Whether Rev has the ability to diffuse along the
lattice is unknown but seems less likely. In the case of MCAK, a relatively larger
protein, there is present a neck region that sterically hinders tight binding to the MT
lattice. This hindrance is removed once it reaches the MT ends. Alternatively, Rev
has the ability to multimerize meaning that it might have the ability to reach the MT
end by multimerizing along the surface of the MT.
If depolymerization depends on the ability of Rev to form oligomers, mutants of
Rev that exhibit multimerization deficiency in the two regions flanking the RNA
binding site (M4 and M7) will not have a depolymerizing effect on the
microtubules. In vitro analysis of Rev multimerization by Brice et al., 1999
indicates that Rev M4 and M7 do not bind the RRE with the same affinity as wildtype Rev and the binding of subsequent monomers is reduced. If the model
proposed above is correct and Rev multimerizes along the microtubule lattice until
it reaches the high affinity ends and causes peeling of the protofilaments, then the
36

mutants of Rev (M4 and M7) should show lower depolymerization activity because
of reduced affinity for the microtubule lattice. Preliminary data indicates that
multimerization may be important for Rev activity, but is not required for
depolymerization (A. Sharma, personal communication). Experiments done by
mixing GMPCPP stabilized MTs with mutants of Rev deficient in multimerization
have the ability to depolymerize microtubules, but not much is known about the
ability of mutants relative to wild-type Rev.
Attempts to purify mutants of Rev protein defective in multimerization (M4 and
M7) or RNA binding (M5 and M6) using similar methods are discussed in detail in
appendix (Figure A1, A2). Purification was hindered by the inability of Rev to bind
the heparin-sepharose column resulting in low concentration of Rev and was
associated with contaminating proteins that made it unsuitable for use in
sedimentation assay. These mutants were excluded from use in sedimentation assay
due to the presence of contaminants.
One of the puzzling observations was that Rev induced depolymerization of
MTs never reaches 100% (Figure 8) suggesting that Rev either is aggregating under
the experimental conditions or is inhibited at the ends. The maximum percentage of
released heterodimer in supernatant is about 45-50%. However, Watts et al. (2000)
did not report seeing any aggregation of Rev under similar buffer conditions which
is confirmed by our experiments (Figure 10). The experiments with Rev alone in
storage buffer and in MT dilution buffer agree with no aggregation under our
experimental conditions. Alternatively, it is possible that ring intermediates (3.4-4.2
MDa) that are intermediate products of depolymerization are pelleted upon high
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speed centrifugation. This seems unlikely since the citrate ions in our buffer
conditions are present in molar excess relative to magnesium meaning that rings are
likely not formed (Watts et al., 2000). Furthermore, Watts et al. (2000) experiments
show that GMPCPP stabilized MTs mixed with Rev results in the formation of
spirals under similar buffer conditions. If Rev forms spirals with stabilized MTs, it
is likely that only half of Rev forms these structures at the ends of MTs, and the rest
forms collar like structure preventing further interaction with Rev. Preliminary data
using transmission electron microscopy (TEM) to visualize the product of Rev-MT
interaction does not show formation of ring-like structures that Watts et al. (2000)
observed (Trombley, Hertzer, Miller, personal communication). Finally, it is
possible that Rev is not as functional as it is thought to be. To test the functionality
of Rev, EMSA can measure the ability of our Rev to bind RRE.

Proposed Model
In the event that Rev binds along the lattice with the same affinity as the ends, it
likely binds the microtubule along the lattice as a monomer, multimerizes along the
lattice due to Rev-Rev and Rev-tubulin interactions until it reaches the ends where
it forms curved structures similar to the ones seen by Watts et al. (2000) (Figure
11). If this model is true, Rev will bind the MTs at lower concentrations without
causing depolymerization and at medium or high concentrations of Rev,
depolymerization activity should be seen. Whether Rev binds the middle of the MT
lattice or a site closer to the ends will affect the critical concentration required to
cause activity but in either case, multimerization likely plays an important role.
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If, however, the binding affinity for the ends is higher than the lattice, the
depolymerization activity should be observed at low concentrations of Rev. This is
consistent with the results seen in our sedimentation assay in which maximal
depolymerization activity was observed at a Rev:tubulin molar ratio of 4:1.
Rev likely binds the high affinity ends of the microtubule and stabilizes the curved
protofilament leading to the depolymerization. This is the similar to that of Kinesin
13 induced depolymerization of microtubules. To determine what residues of Rev
are responsible for binding and depolymerization, mutant forms of Rev that harbor
mutations in regions responsible for Rev activity can be used in sedimentation
assays to see their activity relative to wild type Rev.
To calculate the number of binding sites at the ends relative to those on the MT
polymer, the length of MT polymer under our conditions had to be measured. The
length of the MT is roughly 17.5 µm ( Sharma, A. Personal Communication). Since
the length of tubulin heterodimer is 8 nm, the concentration of tubulin at ends vs.
the lattice is 35.6 nM and 2.9 µM respectively. In terms of ratio of the number of
binding sites at the ends vs. along the lattice, it is 1:1092. Arguing that Rev binds
the ends and lattice equally, and two Rev monomers bind one tubulin heterodimer,
then the lattice could act as a sink. Therefore, low concentrations of Rev are not
expected to cause depolymerization of MTs. However, data indicates that Rev is
capable of depolymerizing at a molar ratio of 1:10. This raises the possibility that
either two monomers of Rev release more than one heterodimer of tubulin or Rev
has higher affinity for MT ends. Watts et al., 2000 have shown that RTTs contain
equimolar amounts of Rev and tubulin monomers, therefore, it is unlikely that more
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than one heterodimer is released. The preference for ends better explains the RevMT interactions under these conditions and is consistent with the data obtained
from the sedimentation assay.

Future Experiments
Electron microscopy with the samples used in sedimentation assay can reveal
curved structures to confirm depolymerization. Also, visual assay that relies on
immunostaining using Rev and tubulin specific antibodies can show where Rev
binds on the MT. Even if the MTs get shorter over time, it confirms the findings of
sedimentation assays. Further characterization of Rev-MT binding could be seen by
assessing the folded state of Rev using circular dichroism spectrum and RRE
binding experiments that use electrophoretic mobility shift assays (EMSAs) to
measure RNA affinities.
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Figure. 1. Structure of HIV-1 Rev showing domains important during HIV
function. The amino-terminal domain of the 116 amino acid protein consists of
arginine-rich motif (ARM) that serves as the nuclear localization signal (NLS) and
as the RRE-binding domain. The amino terminus is believed to assume a helixloop-helix (Auer et al., 1994, Thomas et al., 1998) as is depicted in figure below.
Helix1 and helix2 segments span residues 8-26 and residues 34-59 respectively. On
either side of the ARM are regions important for multimerization of Rev monomers
on the RRE. The C-terminal domain consists of leucine-rich region known as the
activation domain containing the nuclear export signal (NES).
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Figure. 2. Alignment of Rev amino acid sequence with region of the catalytic
domain of two Kinesin-13 proteins XMCAK and KIF2C and motile kinesin
KIF1A to show sequence similarity between the proteins. Residues in red are
identical, residues in green are conservative substitutions, and residues in blue are
similar substitutions.
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Rev:
XMCAK
KIF2C
KIF1A

34 TRQARRNRRRRWRERQRQIHSISERILSTYLGRSAEP
506 TASADRITRMEGAEINRSLLALKECIRALGQNKSHTP
502 TSSADRQTRMEGAEINKSLLALKECIRALGQNKAHTP
260
AKGTRLKEGANINKSLTTLGKVISALAEMDSGPN
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Figure 3: Top: Catalytic domain of motile kinesin KIF1A showing MT-binding
regions in green and region homologous to part of Rev in cyan (Niederstrasser
et al., 2002). Below: X-ray crystal structure (nucleotide not present) of MT
depolymerizing Kinesin-13 protein pKinI showing important areas (adapted from K
Shipley et al., 2004). Part of MT-binding surface is shown in green (L12), loop
L11 and helix4 which contacts both the MT and the nucleotide are shown in
red. Loop L11, helix α4, and loop L12 are the main MT-binding elements.

45

46

Figure 4: SDS-PAGE showing expression of wild-type Rev in BL-21(DE-3)
cells before and after induction with 1 mM IPTG during mid-log phase. Rev
migrates to position that corresponds to 18 kDa on the gel.
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Figure 5: Purification of wild-type Rev. Clarified cell extracts of Rev expressing
BL21(DE3) cells were FPLC purified by a combination of Q-Sepharose and
heparin-Sepharose columns. (A) Q-Sepharose column FPLC chromatogram. (B)
Heparin-Sepharose column chromatogram. (C) Protein fractions from the QSepharose column resolved by SDS-PAGE showing WCE (Whole Cell Extract)
that has high concentration of proteins of different molecular weights, FT (Flowthrough) fractions consist of proteins that did not bind the column. CW (Column
wash) fractions and EL (Elute) fractions show Rev eluted with 800 mM NaCl. (D)
Fractions from the Q-Sepharose column containing Rev were pooled and
chromatographed over heparin-sepharose column. Rev elutes as a single band as a
purified protein. (E) Purified protein was denatured with 6M urea and dialyzed
against citrate buffer to form Rev filaments. The protein was concentrated using
centricon-30. Quantitation of Rev using BSA concentrations as standards (NIH
image). (F) Graphical representation of the quantitation of wild-type Rev (R2=0.9).
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Fig 6: SDS-PAGE of purification of tubulin from bovine brains.
Chromatographic profile of purified tubulin (A) and microtubule associated proteins
(MAPS) (B) as the proteins come off as flow-through and elute fractions
respectively from the phosphocellulose (PC) column. The chromatographs are from
the same purification separated by 24 hrs. Purified tubulin shows a single band that
migrates to a position corresponding to 50 kDa on a gel (C).
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Figure 7: Rev induced time dependent depolymerization of microtubules. (A)
Left: Western blot showing Rev alone placed in buffer alone (no MTs) and spun at
the time (min) as indicated, and supernatant (S) and pellet (P) separated, and
resolved by SDS-PAGE to calculate the percentage of pelletable protein during 60
min. Right: SDS-PAGE showing MT controls obtained by placing MTs in buffer
alone (no Rev) at time points (min) as indicated. (B) SDS-PAGE showing no
depolymerization of MTs in absence of Rev in lanes 1-8, indicating MTs are stable
in MEM buffer. Lanes 9-10 show depolymerization by addition of Rev after 60 min
in the same experiment. Last lane is from the same experiment but resolved on a
different gel. (C) SDS-PAGE showing Rev induced depolymerization of MTs is
time-dependent in lanes 1-8 at time points (min) indicated, lanes 9-10 are Rev
controls in buffer alone, no MTs at 10 min. Also noticeable is the shift of Rev to the
pellet when mixed with MTs in lanes 4, 6, 8. (D) Quantitation of depolymerization
both in percentage of tubulin released and the number of micromoles of MT
polymer left in the pellet (average of three independent experiments) with standard
deviations. Bottom pink line indicates quantitation of MT controls for comparison.
Analysis of data indicates that time is strongly significant (p < 0.0001), with
parameter estimate 0.3942, indicating that the slope of this regression line is
significantly different from zero.
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Figure 8: Quantitation of tubulin released in supernatant at different Rev
concentrations as indicated. (A) SDS-PAGE showing increased shift of tubulin to
the supernatant with the addition of increasing concentrations of Rev after 10 min.
(B) Depolymerization shows saturation at molar ratio of 4:1. Lines indicate time
points at which depolymerization was measured (10 min-Blue, 25 min-Pink, and 40
min-Yellow). Statistical analysis was done using one-way ANOVA with factor
dilution. This model ignored time, effectively pooling all the data at a given dilution
level into one group. This was marginally significant (p = 0.0648). The data at
concentration of 300 nM, indicated by asterisk, was found to be significantly
different from control.
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0.015

Figure 9: SDS-PAGE showing equimolar Rev and MTs (+) or MTs in buffer
alone (-) incubated for 20 min and centrifuged at the g values as indicated.
Below: Quantitation of tubulin released in supernatant at the g values as indicated.
Statistical analysis was done by a two-way ANOVA with percentage of tubulin as
the dependent variable and factors speed (5 levels) and group (2 levels: control or
Rev+MT). The model was strongly significant, but the interaction term was not
significant. By removing the interaction term, the final model with main effects
only was strongly significant (p = 0.0001) (See Materials and Methods).
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Figure 10: Western blot showing that Rev exists as a monomer in high salt
elution buffer and show primarily in supernatant (S) upon centrifugation at 10
min. Rev filaments, when stored properly according to Watts et al., 2000, are
present mainly in the pellet (P) fraction after centrifugation at time points indicated.
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Figure 11: Rev undergoes degradation upon storage for 4-5 months. SDSPAGE (1) and western blot (2) showing purified Rev as a single band from the
heparin-sepharose column. SDS-PAGE (3) showing the appearance of Rev derived
smaller peptides (shown as small arrows) in addition to the full-length protein
(larger arrow) after storage for 5 months. This degradation correlates to loss of
depolymerization activity as seen in sedimentation assay.
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Figure 12: Proposed models to explain Rev induced depolymerization of MTs.
Structure of a single microtubule, indicating slant in the diagram, tubulin
heterodimer shown in red and blue. (Modified from microtubule structure at
www.med.unibs.it/marchesi/pps97/sec11/assembli.html). Rev is shown as white
squares. (A) Rev can either bind high affinity ends of MTs like Kinesin-13 to
remove heterodimers from the ends. (B) Alternatively, Rev can bind along the MT
lattice, multimerize to reach the ends, and cause release of heterodimers.
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Appendix
Figure A1. Purification of Rev mutant M4: SDS-PAGE showing fractions from
the Q-sepharose column (top) and heparin sepharose column (bottom).
Contaminating proteins came off the Q-sepharose column as flow-through (FT) and
Rev-RNA eluted in 800 mM NaCl (EL) that was chromatographed over the heparin
column. Rev came off the column in 1M NaCl with the contaminants and did not
show a significant band in elute (EL) fractions. Ammonium sulfate precipitation did
not yield high concentration of purified Rev.
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Figure A2. Purification of Rev mutant M7. SDS-PAGE showing fractions from
the Q-sepharose column (top) and heparin-sepharose column (bottom). Clarified
cell lysate was loaded on the Q-sepharose column (L) that resulted in the removal
of most of the contaminating proteins (FT) and Rev-RNA complexes eluted in 800
mM NaCl (EL). Fractions containing Rev (S) were chromatographed over the
heparin column that resulted in Rev not binding the column and coming off with the
contaminants in 1M NaCl (FT) without any peak detected on the chromatograph or
any protein band detectable on coomassie stained gel.
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Purification of mutant form of Rev that harbors point mutations in
multimerization domain was attempted using the same method that was used to
purify wild-type Rev. Multimerization is important for Rev function and mutant M4
and M7 are unable to multimerize on the mRNAs. Brice et al., 1999 have shown
that these mutations are present in the exposed hydrophobic surface on Rev and
likely disrupt the multimerization interfaces leading to defects in forming oligomers
on the RRE,
Clarified cell lysate was prepared similar to that described for wild-type Rev
purification (see Materials and methods) and chromatographed over the Qsepharose column and heparin-sepharose column (Amersham Biosciences). The
majority of the contaminant proteins did not bind the Q-sepharose column and came
off in the flow-through (400 mM NaCl) as indicated in lanes 1-4 in the coomassie
stained gel above. A step gradient was applied with 800 mM NaCl containing
buffer B and Rev eluted as fairly purified proteins as seen by the presence of a
single band in lanes marked EL on a gel. Fractions containing Rev were
chromatographed over the heparin column equilibrated in buffer B (800 mM NaCl),
washed with five column volumes of buffer C (1M NaCl) until the conductance
leveled to the base line. A step gradient was applied in 2M NaCl containing buffer
D for 4 column volumes. As seen in the gel, most of the contaminants and Rev
came off in the flow-through (FT) and a faint band containing Rev is seen in the
elute fractions. Attempts were made to collect the flow-through from the heparin
column, and its salt concentration and pH adjusted to that of heparin column
binding buffer (800 mM NaCl), and chromatographed again over the heparin
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column. There was no peak detected on the chromatogram or protein band detected
on a coomassie stained gel indicating that Rev M4 either did not bind the heparin
column or the concentration was very low.
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Solutions
1.1. Staining Solution- 0.1% Coomassie Brilliant Blue, 50% MeOH, 10% HoAc
45% methanol
9% acetic acid
0.25% (weight) Coomassie
2. Destaining solution- 35% methanol
10% glacial acetic acid
3. 10 X Running Buffer- 30g Tris, 144g Glycine, 10g SDS. Add water to 1L
4. 10X Transfer Buffer- 15.1 g Tris, 72g Glycine, Add water to 1L
5. Blocking solution- 5% Non-fat dry milk in TBST
0.1% NaN3
Stored at 40C
6. 20% ammonium persulfate (APS)- Dissolve 2.0 g ammonium persulfate in 10 ml
water and aliquot into 1 ml tubes and freeze at -20oC.
7. Antibodies used in sedimentation assay
Rev detection
Primary antibody- Rabbit antiserum, 2% BSA, 0.1% NaN3 (1:1800) in 1X TBST
Secondary antibody- HRP Goat antirabbit in 5% BSA, 1X TBST
Rev and tubulin detection
Primary Ab- Rabbit antiserum (1:1800), DM1A (1:5000) in 1X TBST
Secondary Ab- HRP donkey antimouse (1:100,000), Goat antisheep (1:100,000) in
5% BSA, 1X TBST
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Formatted: Bullets and Numbering

8. Lower resolving Gel
ddH2O

2.95 ml

4 x lower gel buffer

2.50 ml

Lower gel Acrylamide 4.45 ml
20% APS
Temed

41.25 µl
10 µl

9. Upper stacking Gel
ddH2O

3.1 ml

4 x Upper gel buffer

1.25 ml

Upper gel Acrylamide 0.65 ml
20 % APS
Temed

16.5 µl
5 µl

10. 10X TBST-1.5 M NaCl, 200 mM Tris, pH 7.2-7.5, 0.1% Tween-20
11. Blot stripping buffer- 25 mM Glycine, 1% SDS pH 2.0
12. 2X Protein sample buffer (1X=62.5 mM Tris-HCl, pH 6.8, 10% glycerol, 2%
SDS, 5% 2 mercaptoethanol, 0.025 % BFB)
4 x Upper gel buffer
Glycerol
10% SDS
Me
1% BFB
Total volume

2.5 ml
2.0 ml
4.0 ml
1.0 ml
0.5 ml
10.0 ml

13. Rev purification Buffers (FPLC)
Karn A- 400 mM NaCl, 50 mM Tris-HCl pH 8.0, 1 mM EDTA, 1 mM DTT, 0.5
mM phenyl-methylsulfonyl fluoride (PMSF)
Karn B- 800 mM NaCl, 50 mM Tris-HCl pH 8.0, 1 mM EDTA, 1 mM DTT
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Karn C- 1M NaCl, 50 mM Tris-HCl pH8.0, 1mM EDTA, 1mM DTT
Karn D- 2M NaCl, 50 mM Tris-HCl pH 8.0, 1 mM EDTA, 1 mM DTT
Dialysis buffer 1 (50 mM sodium phosphate, 150 mM sodium chloride, 600 mM
ammonium sulfate, 50 mM sodium citrate, 1mM EDTA pH 7.0)
Dialysis buffer 2 (50 mM sodium phosphate, 150 mM sodium chloride, 50 mM
sodium citrate, 1mM EDTA pH 7.0
Dialysis buffer 3 (20 mM Hepes, 100 mM sodium chloride, 50 mM sodium citrate,
1 mM EDTA pH 7.0), also acts as storage buffer
14. Pipes buffer- 0.1 M Pipes, pH 6.8, 0.5 mM MgCl2, 2 mM EGTA, 0.1% B-ME, 1
mM ATP
15. Column Buffer- 50 mM Pipes, pH 6.8, 1 mM EGTA, 0.2 mM MgCl2
16. MEM buffer- 100 mM MES, 1 mM MgCl2, 1 mM EGTA pH 6.9
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